Immunizations could be administered within minutes where and when a disease is breaking out.
Vaccines combat diseases and protect populations from outbreaks, but the life-saving technology leaves room for improvement. Vaccines usually are made en masse in centralized locations far removed from where they will be used. They are expensive to ship and keep refrigerated and they tend to have short shelf lives.
University of Washington engineers hope a new type of vaccine they have shown to work in mice will one day make it cheaper and easy to manufacture on-demand vaccines for humans. Immunizations could be administered within minutes where and when a disease is breaking out.
“We’re really excited about this technology because it makes it possible to produce a vaccine on the spot. For instance, a field doctor could see the beginnings of an epidemic, make vaccine doses right away, and blanket vaccinate the entire population in the affected area to prevent the spread of an epidemic,” said François Baneyx, a UW professor of chemical engineering and lead author of a recent paper published online in the journal Nanomedicine.
In typical vaccines, weakened pathogens or proteins found on the surface of microbes and viruses are injected into the body along with compounds called adjuvants to prepare a person’s immune system to fight a particular disease. But standard formulations don’t always work, and the field is seeking ways to manufacture vaccines quicker, cheaper and tailored to specific infectious agents, Baneyx said.
The UW team injected mice with nanoparticles synthesized using an engineered protein that both mimics the effect of an infection and binds to calcium phosphate, the inorganic compound found in teeth and bones. After eight months, mice that contracted the disease made threefold the number of protective “killer” T-cells – a sign of a long-lasting immune response – compared with mice that had received the protein but no calcium phosphate nanoparticles.
The nanoparticles appear to work by ferrying the protein to the lymph nodes where they have a higher chance of meeting dendritic cells, a type of immune cell that is scarce in the skin and muscles, but plays a key role in activating strong immune responses.
In a real-life scenario, genetically engineered proteins based on those displayed at the surface of pathogens would be freeze-dried or dehydrated and mixed with water, calcium and phosphate to make the nanoparticles. This should work with many different diseases and be especially useful for viral infections that are hard to vaccinate against, Baneyx said.
He cautioned, however, that it has only been proven in mice, and the development of vaccines using this method hasn’t begun for humans.
The Latest on: Vaccines
via Google News
The Latest on: Vaccines
- How Do COVID-19 Vaccines Compare?on March 5, 2021 at 8:16 am
While direct comparisons can't be made because head-to-head trials don't exist, people are questioning how the three COVID-19 vaccines authorized in the U.S. stack up. Below are the key ...
- The latest on the coronavirus pandemic and vaccineson March 5, 2021 at 7:32 am
The coronavirus pandemic has brought countries to a standstill. Meanwhile, vaccinations have already started in some countries as cases continue to rise. Follow here for the latest.
- Businesses to Buy Covid-19 Vaccines for Employees in Indonesia’s Plan to Ease Pandemicon March 5, 2021 at 7:30 am
With vaccinations lagging, Indonesia’s government has authorized private companies to acquire Covid-19 vaccines, but some public-health experts say the strategy will steer shots toward the ...
- Ghana is using drones to deliver coronavirus vaccines to rural communitieson March 5, 2021 at 5:26 am
Zipline has started delivering coronavirus vaccines via drone in Ghana as part of COVAX's first-ever shipment of vaccines to low-income countries.
- French minister Beaune: EU must be united over Russian, Chinese vaccineson March 5, 2021 at 4:41 am
The solidarity of the European Union would be impacted if countries in the bloc chose Chinese or Russian COVID-19 vaccines which have not yet been approved, French European Affairs minister Clement ...
- Covid vaccines: WHO chief backs patent waiver to boost productionon March 5, 2021 at 4:06 am
Dr Tedros Adhanom Ghebreyesus says world needs to be ‘on a war footing’ against virus ...
- Great apes given Covid vaccines after outbreak at San Diego zooon March 5, 2021 at 2:57 am
Eight infected gorillas had symptoms including runny noses, coughing and lethargy ...
- Moldova is first European country to receive COVID-19 vaccines under COVAXon March 5, 2021 at 12:36 am
Moldova became the first European country to receive COVID-19 vaccines from the global COVAX scheme, Moldovan President Maia Sandu said on Friday.The first batch of 14,400 doses arrived in Moldova ...
- Great apes at the San Diego Zoo got coronavirus vaccines: ‘These animals are incredibly precious’on March 5, 2021 at 12:26 am
The San Diego Zoo Wildlife Alliance said last month four orangutans and five bonobos received two doses of a coronavirus vaccine made specifically for animals.
- WHO head pushes for waiver of some intellectual property rights to coronavirus vaccines, in bid to broaden accesson March 5, 2021 at 12:20 am
In recent days Tedros has made his most pointed plea yet for the waiver of some patents — the intellectual property protections behind vaccine formulations — for coronavirus vaccines and medical ...
via Bing News